Now I have enough information to write the updated review. Let me carefully verify the key claims.---

## Summary

LoRA-Mixer is a Mixture-of-Experts framework that inserts LoRA experts into the projection (Q/K/V) matrices of attention layers rather than FFN blocks or parallel branches, enabling compatibility with both Transformer and SSM architectures. It pairs this placement with a Routing Specialization Balance Loss (RSL), an entropy-augmented auxiliary loss claimed to promote task-aware routing while maintaining global load balance. Evaluations span 15 benchmarks across five domains and three base models.

---

## Rebuttal Assessment

**Weakness 1: RSL formula directly contradicts its stated mechanism**
- **Author's response:** Partially address
- **Assessment:** Partially convincing — The authors correctly acknowledge that Design Principle #1 is "incorrectly stated." They confirm the formula in Eq. 5 does maximize entropy, not minimize it, and correctly identify this as consistent with the Introduction's framing of RSL as "maintaining moderate entropy to encourage exploratory behavior" (verified in line 26 of the paper). This is a meaningful clarification: the formula is correct and one authoritative description in the Introduction is also correct. However, the rebuttal fails to recognize that Section 3.3 contains **multiple** contradictions beyond Design Principle #1, all of which remain in the paper text: (a) "suppressing overly flat distributions" is directly wrong — entropy maximization makes distributions flatter, not less flat; (b) "peaked distributions" (line 110) contradicts entropy maximization, since peaked = low entropy; (c) the "strong convexity" claim in Appendix A.1 remains suspect because $-\lambda\mathcal{H}$ adds negative, not positive, curvature to the Hessian. The rebuttal presents (b) as a *correct* description of the mechanism without recognizing that "peaked distributions" is incompatible with entropy maximization. Promises to fix only Design Principle #1 while leaving the other contradictions in place.
- **Score impact:** Weakness downgraded (from fatal/major to major) — the formula is correct and the Introduction is coherent, but Section 3.3 has at least three unresolved contradictions, not one.

---

**Weakness 2: Headline gains in abstract not traceable to main comparison tables**
- **Author's response:** Partially address (acknowledge)
- **Assessment:** Unconvincing — The rebuttal explicitly concedes: "because the abstract does not cite the specific table and competitor, the claim as written cannot be verified solely from the main text." The authors speculate the figures may come from appendix tables (A.3, A.12, A.14), which are stripped from the parseable text. Tracing from the main tables confirms the figures don't appear: CoLA +2.90% vs. best is unverifiable (closest is Mistral +3.56 vs. MixLoRA, a different model); ARC-C +3.95% cannot be found (Table 8 shows +3.36 vs. AESL); GSM8K +3.79% appears nowhere in any main table. The acknowledgment that this is a "presentation deficiency" is honest but does not resolve the issue.
- **Score impact:** Weakness unchanged.

---

**Weakness 3: Training data parity for Table 2 not stated**
- **Author's response:** Acknowledge
- **Assessment:** Unconvincing — Authors confirm the explicit statement is absent for Table 2 and promise to add it. "Will add" does not count as evidence already in the paper.
- **Score impact:** Weakness unchanged.

---

**Weakness 4: Medical QA evaluation via LLM judge not justified**
- **Author's response:** Partially address
- **Assessment:** Unconvincing — The paper's only justification remains "domain-specific freedom and rigor required by the Medical-QA dataset" (line 136). The rebuttal adds the framing that the evaluation targets "open-ended clinical reasoning outputs," but MedQA-style benchmarks are standard multiple-choice with gold labels; the LLM judge choice is not justified, and parallel exact-match results are promised but not provided.
- **Score impact:** Weakness unchanged.

---

**Weakness 5: RSL underperformance at 4K unaddressed in main text**
- **Author's response:** Acknowledge
- **Assessment:** Unconvincing — Full acknowledgment with a promise to add explanatory text. Table 9 shows RSL underperforms at 4K (−0.37) and nearly ties at 6K (−0.04). No explanation appears in the main text.
- **Score impact:** Weakness unchanged.

---

**Weakness 6: LoRA-LEGO comparison uses a different base model**
- **Author's response:** Partially address (refute on base model specifically)
- **Assessment:** Convincing on the base-model sub-claim — The paper explicitly states (line 154): "We use the LLaMA2-7B from the LoRA-LEGO paper as the basemodel." Both methods use LLaMA2-7B. The original reviewer's concern about a base model advantage is factually wrong; the rebuttal correctly refutes it with paper evidence. The residual concern about uncontrolled experimental conditions (training procedures, data splits) when using LoRA-LEGO's published numbers remains valid and is honestly acknowledged.
- **Score impact:** Weakness downgraded (from minor to trivial/minor).

---

## Strengths

1. **Architecture-agnostic projection-layer placement.** Inserting LoRA experts into projection matrices (rather than FFN or parallel branches) allows compatibility with Falcon-Mamba-7B (a pure SSM with no FFN layers), producing consistent gains across all seven benchmarks in Table 2. This is a genuine differentiator not demonstrated by MixLoRA or MoLE.

2. **Plug-and-play routing over Internet-sourced LoRAs.** Table 3 shows five publicly downloaded LoRA adapters on Flan-T5 with only 2K routing samples outperforming individually fine-tuned LoRA on four of five GLUE tasks by +2.14 on CoLA and +1.84 on RTE.

3. **Demonstrated data efficiency.** Table 9 shows RSL achieves competitive average accuracy with 1K–2K samples while the standard auxiliary loss requires ~6–8K to reach similar levels. Figure 4 shows clear domain-aware routing specialization under RSL (Expert 1 ~35% on Medical, Expert 2 ~38% on GSM8K).

4. **Consistent empirical gains.** Table 2 shows LoRA-Mixer outperforming all baselines on most tasks across all three base models. Table 8 shows RSL outperforming GMoE, DS-MoE, and AESL under identical 2K budgets with margins up to +6.86 on ARC-C vs. GMoE.

---

## Weaknesses

### Fatal
None.

### Major

**1. Section 3.3 contains multiple unresolved contradictions between verbal description and the formula.** The rebuttal acknowledges only Design Principle #1 as incorrectly worded. But Section 3.3 also says RSL works by "suppressing overly flat distributions" (line 86) — directly wrong, since Eq. 5 when minimized maximizes entropy, making distributions *flatter*, not less flat. It also says RSL "encourages…peaked distributions" (line 110) — peaked means low entropy, contradicting the entropy-maximizing formula. The rebuttal presents "peaked distributions" as a *correct* description, failing to see this as a third inconsistency. Only the Introduction's framing ("maintaining moderate entropy to encourage exploratory behavior") is coherent with the formula.

**2. Headline gains in the abstract remain unverifiable from main text tables.** The abstract claims "+3.79% on GSM8K, +2.90% on CoLA, +3.95% on ARC-C" against state-of-the-art baselines. These figures do not appear in Tables 2, 3, 4, 5, 6, 7, or 8. The rebuttal acknowledges they "cannot be verified solely from the main text" and speculates they come from appendix tables (A.3, A.12, A.14). This is acknowledged misrepresentation.

### Minor

**3. Training data parity for Table 2 baselines not stated.** Since data efficiency is a central claim, the absence of an explicit statement about training data for all methods in Table 2 is material. Acknowledged by authors; no fix in the paper.

**4. Medical QA evaluation via LLM judge unjustified.** DeepSeek-R1 is used as judge for a benchmark with gold labels; no exact-match comparison provided; cross-paper comparisons in Table 2 are compromised.

**5. 4K anomaly deferred to appendix without main-text explanation.** Table 9 shows RSL underperforms at 4K (−0.37) and nearly ties at 6K (−0.04), with the main text only pointing to A.16.

### Trivial

**6. LoRA-LEGO experimental conditions differ (base model is the same).** Both use LLaMA2-7B (refuted by rebuttal). Residual concern: LoRA-LEGO numbers come from its original paper under potentially different training conditions; RTE drop (61.47 vs. 71.85) unexplained.

---

## Nice-to-Haves

- A controlled ablation isolating placement contribution (projection-layer vs. FFN-layer LoRA-MoE, same routing loss, same data).
- Variance estimates across three runs given several margins in Table 2 are below 1 point.
- Explicit parameter count table in the main body to verify the "48% efficiency" claim.

---

## Novel Insights

The paper's most interesting empirical finding — read honestly — is that a formula that maximizes per-token routing entropy (preventing premature routing collapse) yields strong data efficiency advantages at low data scales (1K–2K) while the advantage shrinks or reverses at moderate data sizes (4K–6K). This is a coherent and empirically interesting story about entropy regularization on the routing simplex as a form of exploration. The projection-layer placement enabling SSM compatibility is independently valuable and underexplored. The rebuttal clarifies that the Introduction correctly describes this mechanism, even though Section 3.3 contradicts it in multiple places.

---

## Suggestions

1. **Revise Section 3.3 comprehensively.** Design Principle #1 must be corrected (acknowledged by authors), but also: "suppressing overly flat distributions" and "peaked distributions" must be removed or corrected. The correct framing — maintained in the Introduction — is entropy *maximization* as an exploratory regularizer preventing premature routing collapse.

2. **Trace the abstract's headline numbers explicitly** to specific tables and competitors, or replace with directly verifiable figures from Tables 2 and 8 with explicit attribution.

3. **State training data quantities for all methods in Table 2** with a single sentence.

4. **Provide a one-sentence hypothesis in the main text for the 4K anomaly** rather than pointing to A.16.

5. **Include parallel exact-match results for Medical QA** alongside the LLM judge scores.

---

## Score Assessment

The rebuttal makes two genuine contributions: (1) correctly refuting the base-model weakness for LoRA-LEGO (both use LLaMA2-7B), and (2) providing a more coherent framing of RSL's intended mechanism (entropy-maximizing, consistent with the Introduction and the formula). These are meaningful but limited. The RSL weakness is downgraded from "formula is wrong" to "multiple verbal contradictions in Section 3.3 that the authors have only partially recognized and committed to partially fixing." The abstract's headline figures remain unverifiable. Three other minor weaknesses are acknowledged but unfixed. The score moves marginally upward from the original 5.0 but remains below the acceptance threshold — the paper needs significant revision to its theoretical presentation and abstract before it merits publication.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>